Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome

[1]  D. Mavroudis,et al.  Prognostic significance of RASSF1A promoter methylation in operable breast cancer. , 2009, Clinical biochemistry.

[2]  Bongsoo Park,et al.  BMC Genomics , 2007 .

[3]  K. Metze,et al.  Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis , 2008, BMC Cancer.

[4]  Xin Hu,et al.  Correlation between CpG methylation profiles and hormone receptor status in breast cancers , 2007, Breast Cancer Research.

[5]  E. Estey,et al.  RIL, a LIM gene on 5q31, is silenced by methylation in cancer and sensitizes cancer cells to apoptosis. , 2007, Cancer research.

[6]  Li Yu,et al.  [DNA methylation and cancer]. , 2005, Zhonghua nei ke za zhi.

[7]  F. Latif,et al.  Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. , 2005, Cancer research.

[8]  G. Pfeifer,et al.  The tumor suppressor RASSF1A in human carcinogenesis: an update. , 2005, Histology and histopathology.

[9]  Therese Sørlie,et al.  Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. , 2004, European journal of cancer.

[10]  Martin Widschwendter,et al.  Association of Breast Cancer DNA Methylation Profiles with Hormone Receptor Status and Response to Tamoxifen , 2004, Cancer Research.

[11]  Kornelia Polyak,et al.  Very High Frequency of Hypermethylated Genes in Breast Cancer Metastasis to the Bone, Brain, and Lung , 2004, Clinical Cancer Research.

[12]  R. Bast,et al.  Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. , 2003, Cancer research.

[13]  C. Osborne,et al.  Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  K. Lunetta,et al.  HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Yang,et al.  Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. , 2001, Cancer research.

[16]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[17]  W. McGuire,et al.  Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  W. McGuire,et al.  Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  W. McGuire,et al.  Measurement of progesterone receptor in human breast cancer biopsies. , 1979, Cancer research.

[20]  M. DeLaGarza,et al.  Evaluation of estrogen receptor assays in human breast cancer tissue. , 1977 .

[21]  Therese Sørlie,et al.  Molecular classification of breast tumors: toward improved diagnostics and treatments. , 2007, Methods in molecular biology.

[22]  Martin Widschwendter,et al.  Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2/neu status in primary breast cancer. , 2006, Cancer research.

[23]  G. Clark,et al.  S-phase fraction and breast cancer - a decade of experience , 1998, Breast Cancer Research and Treatment.

[24]  W. McGuire,et al.  Evaluation of estrogen receptor assays in human breast cancer tissue. , 1977, Cancer research.